Foreign groups in China are being restricted from transferring their research data abroad, hampering international scientific collaboration and hitting pharmaceutical companies the hardest, according to China-based lawyers.
據(jù)一些在中國執(zhí)業(yè)的律師表示，在華外資集團(tuán)被限制向國外轉(zhuǎn)移它們的研究數(shù)據(jù)，這會(huì)阻礙國際科技合作，而制藥公司受到的打擊將最為嚴(yán)重。
您已閱讀6%（286字），剩余94%（4763字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。